Flash Finance

Sree Rayalaseema Hi-Strength Hypo LimitedSRHHYPOLTDCorporate

Chemicals Latest results: Jun 2026 15 quarters of data
Consolidated Standalone
₹527.85
MCap ₹906 Cr · P/E 9.7
Sree Rayalaseema Hi-Strength Hypo Limited — Stock analysis & AI research Sree Rayalaseema Hi-Strength Hypo Limited — Seasonality — best & worst months Sree Rayalaseema Hi-Strength Hypo Limited — Technical setup — score, trend, support & resistance Sree Rayalaseema Hi-Strength Hypo Limited — Live exchange announcements
📋 High Interest Coverage Stocks📋 Stocks Below Book Value 📈 Volume Dry-Up Stocks 🏭 Chemicals sector
AI-assisted data: figures and text on this page are extracted from public quarterly filings with AI assistance, checked automatically and overseen by our editorial team (human in the loop). They may still contain errors or omissions. Verify critical numbers against official company / SEBI / NSE / BSE filings before making any decision. Educational information only, not financial advice.
₹211 Cr
Sales · Jun 2026
+17.0% YoY
₹30 Cr
Operating Profit · Jun 2026
+7.0% YoY
14.2%
OPM % · Jun 2026
-8.4% YoY
₹25 Cr
Net Profit · Jun 2026
+12.3% YoY
₹14.66
EPS · Jun 2026
+12.3% YoY

📝 Sree Rayalaseema Hi-Strength Hypo Limited — results explained

Quarter ended June 2026 (Q1 FY27)

Sree Rayalaseema Hi-Strength Hypo Limited reported revenue of ₹211 crore for the quarter ended June 2026 (Q1 FY27), up 17.0% from ₹180 crore in the same quarter last year, and up 29.4% sequentially over the March 2026 quarter.

Net profit rose 12.3% year-on-year to ₹25 crore, from ₹22 crore. Earnings per share (EPS) came in at ₹14.66.

Operating profit stood at ₹30 crore — an operating margin (OPM) of 14.2%, compared with 15.5% in the year-ago quarter.

Full year and trailing twelve months

For the full year FY26, Sree Rayalaseema Hi-Strength Hypo Limited posted revenue of ₹667 crore, a growth of 4.6% over FY25, with a net profit of ₹91 crore (up 3.2% year-on-year).

On a trailing-twelve-month (TTM) basis, revenue stands at ₹697 crore with a net profit of ₹94 crore.

Valuation snapshot

At the current price of ₹527.85, SRHHYPOLTD has a market capitalisation of ₹906 crore and a trailing P/E of about 9.7.

Within the Chemicals industry, it is the 25th-largest of the 79 companies we track by market value.

Shareholding pattern

As of Sep 2026, promoters held 62.19%, foreign institutional investors (FIIs) 0.30%, domestic institutional investors (DIIs) 0.05%, public shareholders 37.47% of Sree Rayalaseema Hi-Strength Hypo Limited.

Promoter holding rose from 61.84% to 62.19% over the latest period.

📈 Share price & events

📊 Quarterly trend

₹ crore · OPM % on right axis

🎯 Key metrics

price-linked ratios use the latest close
Valuation
Market Cap ?
₹906 Cr
Current Price ?
₹527.9
P/E ?
9.69below ind
Industry P/E ?
24.60
P/B ?
0.93
P/S ?
1.30
P/FCF ?
23.84
Enterprise Value ?
₹918 Cr
EV/EBITDA ?
10.57
PEG ?
N/A
Earnings Yield ?
8.7%
Dividend Yield ?
0.57%
Profitability & Returns
Sales (TTM) ?
₹697 Cr
OPM ?
12.5%
Profit after tax (TTM) ?
₹94 Cr
EPS (TTM) ?
₹54.49
ROCE ?
14.0%
ROE ?
9.6%
ROA ?
8.4%
Growth
Sales — latest qtr ?
₹211 Cr
PAT — latest qtr ?
₹25 Cr
YoY qtr sales growth ?
17.0%
YoY qtr profit growth ?
12.3%
Sales growth (3y) ?
-26%
Sales growth (5y) ?
-6%
Profit growth (3y) ?
-11%
Profit growth (5y) ?
11%
Financial Health
Debt ?
₹12 Cr
Debt to Equity ?
0.01
Interest Coverage ?
92.0
Current Ratio ?
N/A
Ownership
Promoter holding ?
62.19%
Change in promoter holding ?
0.35%
Pledged percentage ?
N/A
Market
Return 3 months ?
7.5%
Return 6 months ?
6.5%

🗓️ Quarterly results (15 quarters · ₹ Cr)

same fiscal quarter as Jun bestweakest per row · for costs (interest, NPAs) low is best
Metric Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026 YoY % QoQ %
Sales 301435261226161165169170138160180182141163211 +17.0% +29.4%
Operating Profit 266435262427262920182827171330 +7.0% +129.9%
Other Income 11201244291315107191210 -4.9% -17.7%
Interest 011162100100001 +19.6% —
Depreciation 553373222221221 -22.0% -29.6%
Profit Before Tax 327933251526263630273132342334 +9.6% +49.3%
Net Profit 247124181120192522222224242025 +12.3% +25.9%
EPS 13.7241.4514.1610.776.4711.3910.8514.7412.5612.8113.0614.2013.8411.6914.66 +12.3% +25.4%
OPM % 8.8% 14.8% 13.5% 11.5% 15.0% 16.4% 15.4% 17.1% 14.5% 11.0% 15.5% 14.8% 12.1% 8.0% 14.2% -8.4% +77.5%

📆 Annual results (₹ Cr, FY = Apr–Mar)

Metric FY25 FY26 TTM YoY %
Sales ₹637 Cr ₹667 Cr ₹697 Cr +4.6%
Operating Profit ₹93 Cr ₹85 Cr ₹87 Cr -8.3%
OPM % 14.53% 12.74% 12.46% -12.3%
NPM % 13.80% 13.62% 13.41% -1.3%
Other Income ₹39 Cr ₹48 Cr ₹48 Cr +23.2%
Depreciation ₹8 Cr ₹7 Cr ₹7 Cr -8.8%
Interest ₹2 Cr ₹1 Cr ₹1 Cr -50.1%
EBIT ₹85 Cr ₹78 Cr ₹80 Cr -8.3%
PBT ₹119 Cr ₹121 Cr ₹124 Cr +1.1%
Tax ₹5 Cr ₹17 Cr ₹17 Cr +216.7%
Net Profit ₹88 Cr ₹91 Cr ₹94 Cr +3.2%
EPS ₹50.96 ₹52.79 ₹54.39 +3.6%
Material Cost ₹95 Cr ₹189 Cr ₹204 Cr +98.6%
Employee Cost ₹8 Cr ₹16 Cr ₹18 Cr +114.1%
Extraordinary Items ₹-3 Cr ₹-5 Cr ₹-4 Cr -55.3%

🏛️ Balance Sheet (latest 4 periods)

Metric Mar 2023Mar 2024Mar 2025Mar 2026 % Chg
Equity Capital 17171717 +0.0%
Reserves 734783901954 +5.9%
Borrowings 19131612 -25.0%
Other Liabilities 175100136133 -2.2%
Total Liabilities 9459141,0701,115 +4.2%
Fixed Assets 105128135132 -2.2%
CWIP 14000 —
Investments 268253349307 -12.0%
Other Assets 558534585677 +15.7%
Total Assets 9459141,0701,115 +4.2%

💧 Cash Flow (latest 4 periods)

Metric Mar 2023Mar 2024Mar 2025Mar 2026 % Chg
Cash from Operating Activity 1411406539 -40.0%
Cash from Investing Activity -112-20-837 +562.5%
Cash from Financing Activity -17-17-18-11 +38.9%
Net Cash Flow 131034065 +62.5%
Free Cash Flow 1331206338 -39.7%
CFO/OP 122%152%105%74% -29.5%

➗ Ratios (latest 4 periods)

Metric Mar 2023Mar 2024Mar 2025Mar 2026 % Chg
Debtor Days 33455946 -22.0%
Inventory Days 39245055 +10.0%
Days Payable 22101813 -27.8%
Cash Conversion Cycle 50599188 -3.3%
Working Capital Days 42598287 +6.1%
ROCE % 26%15%14%14% +0.0%

👥 Shareholding (latest 5 periods)

Metric Jun 2025Sep 2025Dec 2025Mar 2026Sep 2026 % Chg
Promoters 61.84%61.84%61.84%61.84%62.19% +0.6%
FIIs 0.12%0.06%0.06%0.07%0.30% +328.6%
DIIs 0.05%0.05%0.05%0.05%0.05% +0.0%
Public 38.00%38.05%38.05%38.05%37.47% -1.5%
No. of Shareholders 43,53443,08542,52741,80639,723 -5.0%

⚖️ Peer comparison

Industry: Chemicals · top 25 of 79 companies · full page →
# Company CMP MCap (Cr) P/E Sales TTM NP TTM OPM% NPM% Sales YoY% NP YoY% Qtr Rev Δ% Qtr NP Δ%
1 NAVINFLUOR Navin Fluorine ₹8,545.00 43,843 55.4 3,634 790 33.9% 21.7% 41.1% 130.1% 44.1% 107.7%
2 DEEPAKNTR Deepak Nitrite ₹1,596.00 21,768 27.8 8,575 784 15.5% 9.1% -4.8% -22.5% 36.4% 207.4%
3 DEEPAKFERT Deepak Fertilisers ₹1,323.00 16,718 17.0 12,103 985 16.7% 8.1% 12.0% -21.8% 22.5% 101.0%
4 TATACHEM Tata Chemicals ₹615.00 15,668 — 15,120 -1,971 11.3% -13.0% -2.0% -543.2% 14.4% -81.0%
5 PCBL PCBL Chemical ₹331.50 13,043 43.3 6,596 298 13.4% 4.5% -12.5% -46.0% 17.0% 64.8%
6 JUBLINGREA Jubilant Ingrevia ₹647.25 10,208 33.3 4,651 308 13.4% 6.6% 5.1% 10.3% 25.3% 40.9%
7 ALKYLAMINE Alkyl Amines ₹1,818.60 9,301 41.3 1,658 225 20.6% 13.5% -2.3% -3.8% 30.1% 93.1%
8 CLEAN Clean Science ₹820.00 8,715 37.4 982 232 35.7% 23.6% -2.5% -13.7% 21.9% -4.7%
9 GNFC Gujarat Narmada ₹539.75 7,931 7.6 8,410 1,037 14.8% 12.3% -1.5% 35.3% 39.8% 275.9%
10 GALAXYSURF Galaxy Surfactants ₹2,156.30 7,887 21.6 5,752 353 10.4% 6.1% 24.3% -50.0% 39.4% 108.7%
11 NEOGEN Neogen Chemicals ₹2,403.50 7,221 180.9 926 36 16.6% 3.8% 10.9% -17.6% 34.0% 66.8%
12 BALAMINES Balaji Amines ₹2,215.00 7,177 35.3 1,523 211 21.4% 13.9% 2.0% 6.5% 27.2% 113.9%
13 FCL Fineotex Chemical ₹53.07 6,180 41.6 1,012 148 16.7% 14.6% 44.8% 14.5% 174.8% 92.6%
14 ACI Archean Chemical ₹470.90 5,814 61.0 1,123 95 20.3% 8.5% 7.8% -37.0% 8.9% -24.4%
15 GULFOILLUB Gulf Oil ₹1,057.20 5,235 13.9 4,367 371 12.6% 8.5% 11.7% -3.4% 30.6% 27.0%
16 FOSECOIND Foseco India ₹6,846.50 5,186 64.7 618 77 17.5% 12.5% 12.2% -1.9% 9.2% 8.9%
17 GUJALKALI Gujarat Alkalies ₹696.50 5,115 77.0 4,497 66 11.2% 1.5% 7.0% 96.3% 12.6% 499.0%
18 LXCHEM Laxmi Organic ₹178.50 4,961 40.2 3,117 123 8.2% 4.0% -4.7% -43.4% 44.1% 194.8%
19 VISHNU Vishnu Chemicals ₹724.90 4,880 32.6 1,694 150 15.5% 8.8% 11.1% 12.2% 24.9% 23.0%
20 YASHO Yasho Industries ₹4,028.70 4,857 84.9 939 57 19.5% 6.1% 24.0% 771.1% 54.9% 801.3%
21 EPIGRAL Epigral ₹1,084.00 4,677 17.3 2,626 271 22.2% 10.3% -0.9% -7.2% 16.3% -37.9%
22 TATVA Tatva Chintan ₹1,867.60 4,369 85.0 556 51 19.3% 9.2% 32.6% 702.6% 42.8% 128.3%
23 GHCL GHCL ₹418.85 3,839 7.4 3,043 525 23.0% 17.3% -3.7% -23.5% -2.7% 31.8%
24 PREMEXPLN Premier Explosives ₹685.10 3,685 110.0 349 34 6.8% 9.6% -7.0% 60.5% -27.8% -80.2%
25 SRHHYPOLTD Sree Rayalaseema ₹536.15 920 9.9 697 94 12.5% 13.4% 4.6% 3.2% 17.0% 12.3%
❓ Frequently asked questions
What was Sree Rayalaseema Hi-Strength Hypo Limited's revenue in Q1 FY27?
Sree Rayalaseema Hi-Strength Hypo Limited reported revenue of ₹211 crore for the quarter ended June 2026 (Q1 FY27), up 17.0% from ₹180 crore in the same quarter last year, and up 29.4% sequentially over the March 2026 quarter.
What was Sree Rayalaseema Hi-Strength Hypo Limited's net profit in Q1 FY27?
Net profit rose 12.3% year-on-year to ₹25 crore, from ₹22 crore. Earnings per share (EPS) came in at ₹14.66.
What is SRHHYPOLTD's market capitalisation and P/E ratio?
At the current price of ₹527.85, SRHHYPOLTD has a market capitalisation of ₹906 crore and a trailing P/E of about 9.7.
Who owns Sree Rayalaseema Hi-Strength Hypo Limited? (shareholding pattern)
As of Sep 2026, promoters held 62.19%, foreign institutional investors (FIIs) 0.30%, domestic institutional investors (DIIs) 0.05%, public shareholders 37.47% of Sree Rayalaseema Hi-Strength Hypo Limited.
TTM ends 2026-06-30. Amounts are ₹ crore unless stated otherwise. Figures are extracted by AI from public quarterly filings; gaps are filled from public market data. Live price refreshed about twice a day from exchange data. Educational information only — not financial advice.
⚠️ How this site is made: Market data pages are computed automatically from NSE/BSE publications and company filings; news articles and announcement analyses are written with AI assistance, with a human in the loop: our editors review what the AI produces. Both can contain errors. Verify with the original sources before any investment decision. Not investment advice; Flash Finance is not SEBI-registered. How we use AI